awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48246205-7DBFD575-EF96-47CA-A89E-B16C69EBD20E
Q48246205-7DBFD575-EF96-47CA-A89E-B16C69EBD20E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48246205-7DBFD575-EF96-47CA-A89E-B16C69EBD20E
Costs and effectiveness of fingolimod versus alemtuzumab in the treatment of highly active relapsing-remitting multiple sclerosis in the UK: re-treatment, discount, and disutility.
P2860
Q48246205-7DBFD575-EF96-47CA-A89E-B16C69EBD20E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48246205-7DBFD575-EF96-47CA-A89E-B16C69EBD20E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1bb67eb718ddc173bff7f814d4a16901a0d236d5
P2860
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.